Integrated Investment Consultants, LLC Emergent Bio Solutions Inc. Transaction History

Integrated Investment Consultants, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	SELL	$27.42 - $43.63 $167,892 - $267,146	-6,123 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$36.48 - $52.22 $5,508 - $7,885	151 Added 2.53%	6,123 $251,000
Q4 2021 Jan 10, 2022	SELL	$33.11 - $55.01 $231 - $385	-7 Reduced 0.12%	5,972 $260,000
Q3 2021 Oct 28, 2021	BUY	$50.07 - $66.05 $3,204 - $4,227	64 Added 1.08%	5,979 $299,000
Q2 2021 Jul 21, 2021	BUY	$56.61 - $80.46 $123,523 - $175,563	2,182 Added 58.45%	5,915 $373,000
Q1 2021 Apr 20, 2021	BUY	$86.23 - $125.19 $16,987 - $24,662	197 Added 5.57%	3,733 $347,000
Q4 2020 Feb 09, 2021	BUY	$79.17 - $111.47 $1,345 - $1,894	17 Added 0.48%	3,536 $317,000
Q3 2020 Oct 26, 2020	BUY	$81.91 - $134.94 $288,241 - $474,853	3,519 New	3,519 $364,000
Q2 2020 Aug 04, 2020	SELL	$54.33 - $89.52 $196,402 - $323,614	-3,615 Closed	0 $0
Q1 2020 May 22, 2020	BUY	$49.34 - $68.76 $178,364 - $248,567	3,615 New	3,615 $209,000

159

33.7M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $463M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Integrated Investment Consultants, LLC, based on Form 13F filings with the SEC.

Stay updated on Integrated Investment Consultants, LLC with notifications on news.